Browsing: IBN

Greenland Mines (NASDAQ: GRML; FSE: HK6) announced that its board of directors authorized a $20 million share repurchase program as part of an updated capital allocation strategy focused on advancing its core mineral projects, maintaining liquidity and maximizing long-term shareholder

Europe’s online shopping market is still growing, but not as fast as before. According to the latest European E-commerce Report 2026, ecommerce sales across the continent are forecast to rise by 5% in 2026, reaching €961 billion ($1.07 trillion).  This

Amazon has signed a new power agreement backing a wind farm planned for Shetland, adding to a UK renewable portfolio that now runs past 50 separate projects. The deal with Norwegian energy firm Statkraft covers the Mossy Hill site, which

Rezolve Ai (NASDAQ: RZLV) received Court approval for its proposed capital reduction, an important step toward implementing its previously announced share repurchase program of up to $300 million. The approval follows shareholder approval of the capital reduction, with the company

Rezolve Ai (NASDAQ: RZLV) is hosting its Investor Day at Nasdaq MarketSite in New York City, where management will present the company strategy, market opportunity, commercial model, growth drivers and platform for agentic commerce. In conjunction with the event, Rezolve

Beeline Holdings (NASDAQ: BLNE) provided a preliminary update on third-quarter 2026 performance, expecting revenue to reach the second-highest quarterly level in company history and the highest since 2021, while achieving its highest margins to date. Beeline also expects its net

Datavault AI (NASDAQ: DVLT) appointed Christopher R. Hardt to its board of directors as an independent director, effective Oct. 3, 2026. Hardt, who was designated by NYIAX in connection with Datavault AI recently completed acquisition, previously served on the NYIAX

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) has completed its acquisition of Hedia, an Israeli retail media company with fiscal 2025 audited revenue of approximately $20 million. The acquisition combines A2Z Cust2Mate smart cart technology, digital in-store retail media inventory, shopper

Kairos Pharma (NYSE American: KAPA) announced positive interim efficacy data from its ongoing Phase 2 trial evaluating ENV-105 in combination with apalutamide in patients with metastatic castration-resistant prostate cancer. The analysis showed a statistically significant difference in progression-free survival, with

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.